This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2007 Apr 2;26(15):2142-4.

doi: 10.1038/sj.onc.1210276.

Mutant p53: from guardian to fallen angel?

W Deppert¹

Affiliations

PMID: 17401422
DOI: 10.1038/sj.onc.1210276

Mutant p53: from guardian to fallen angel?

W Deppert. Oncogene. 2007.

. 2007 Apr 2;26(15):2142-4.

doi: 10.1038/sj.onc.1210276.

Author

W Deppert¹

Affiliation

¹ Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie, Tumor Virology, Hamburg, Germany. wolfgang.deppert@hpi.uni-hamburg.de

PMID: 17401422
DOI: 10.1038/sj.onc.1210276

No abstract available

PubMed Disclaimer

Similar articles

[The tumor suppressor p53: "guardian of our genomes"].
Deppert W. Deppert W. Med Monatsschr Pharm. 1999 Jun;22(6):166-73. Med Monatsschr Pharm. 1999. PMID: 10394793 Review. German. No abstract available.
Surfing the p53 network.
Vogelstein B, Lane D, Levine AJ. Vogelstein B, et al. Nature. 2000 Nov 16;408(6810):307-10. doi: 10.1038/35042675. Nature. 2000. PMID: 11099028 No abstract available.
[Protein P53, protector of genome integrity: its role in carcinogenesis].
Bellahcene A, Merville MP, Gielen J, Lambotte R, Simar L, Castronovo V. Bellahcene A, et al. Rev Med Liege. 1994 May 1;49(5):274-84. Rev Med Liege. 1994. PMID: 8023054 Review. French. No abstract available.
Mutant p53--the commonest genetic abnormality in human cancer?
Harris AL. Harris AL. J Pathol. 1990 Sep;162(1):5-6. doi: 10.1002/path.1711620103. J Pathol. 1990. PMID: 2231192 No abstract available.
Mutant p53: an oncogenic transcription factor.
Strano S, Dell'Orso S, Di Agostino S, Fontemaggi G, Sacchi A, Blandino G. Strano S, et al. Oncogene. 2007 Apr 2;26(15):2212-9. doi: 10.1038/sj.onc.1210296. Oncogene. 2007. PMID: 17401430 Review.

See all similar articles

Cited by

Versatile functions of p53 protein in multicellular organisms.
Chumakov PM. Chumakov PM. Biochemistry (Mosc). 2007 Dec;72(13):1399-421. doi: 10.1134/s0006297907130019. Biochemistry (Mosc). 2007. PMID: 18282133 Free PMC article. Review.
Anti-apoptotic NF-κB and "gain of function" mutp53 in concert act pro-apoptotic in response to UVB+IL-1 via enhanced TNF production.
Müller I, Beissert S, Kulms D. Müller I, et al. J Invest Dermatol. 2015 Mar;135(3):851-860. doi: 10.1038/jid.2014.481. Epub 2014 Nov 7. J Invest Dermatol. 2015. PMID: 25380350 Free PMC article.
Mutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O(6)-methylguanine DNA-methyltransferase.
Wang X, Chen JX, Liu YH, You C, Mao Q. Wang X, et al. Neurol Sci. 2013 Aug;34(8):1421-8. doi: 10.1007/s10072-012-1257-9. Epub 2012 Dec 8. Neurol Sci. 2013. PMID: 23224642
Manganese superoxide dismutase in cancer prevention.
Robbins D, Zhao Y. Robbins D, et al. Antioxid Redox Signal. 2014 Apr 1;20(10):1628-45. doi: 10.1089/ars.2013.5297. Epub 2013 Jul 18. Antioxid Redox Signal. 2014. PMID: 23706068 Free PMC article. Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal